Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 5:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 12,113 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Non-interventional. Clear all

Conditions: Tissue Banking
Interventions: Not listed
Lead sponsor: University of Central Florida; Other
Eligibility: 18 Years and older
Enrollment: 10,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2075
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Pain During and After Endovenous Laser Obliteration of Large Saphenous Vein Based on Lidocaine Tumescent Concentration
Interventions: Lidocaine; Drug
Lead sponsor: Midwest Vein Center; Other
Eligibility: 16 Years to 85 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Chronic Sinusitis, Adenoid Disease - Chronic
Interventions: Endoscopic Sinus surgery, Adenoidectomy; Procedure
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 6 Years to 12 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: PCOS, Sleep Apnea
Interventions: Screening for obstructive sleep apnea, CPAP - continuous positive airway pressure; Other · Device
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 6
States / cities: Lakeland, Florida • Sarasota, Florida • St. Petersburg, Florida + 2 more

Conditions: Diabetes
Interventions: Continuous Glucose Monitoring (CGM); Device
Lead sponsor: DexCom, Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 1,388 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 25
States / cities: La Jolla, California • La Mesa, California • Sacramento, California + 21 more

Conditions: Glioblastoma
Interventions: Gamma Knife Radiosurgery; Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Stroke
Interventions: Decision tool; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Chronic Spontaneous Urticaria
Interventions: Not listed
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 3,280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Kirksville, Missouri

Conditions: Compartment Syndrome
Interventions: near-infrared spectroscopy; Device
Lead sponsor: J&M Shuler; Industry
Eligibility: 13 Years to 85 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Multiple Sclerosis
Interventions: Behavioral Intervention for Physical Activity in MS (BIPAMS), Wellness for MS (WellMS); Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent
Interventions: Liothyronine (L-T3), Bevacizumab, Irinotecan, Temozolomide (TMZ); Drug
Lead sponsor: Sabine Mueller, MD, PhD; Other
Eligibility: 1 Year to 25 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 3
States / cities: San Francisco, California • Washington D.C., District of Columbia • Seattle, Washington

Conditions: Neoplasms
Interventions: Non-invasive Magnetic Resonance Imaging (MRI), Liver resection, Histopathology diagnosis of resected liver specimen; Other · Procedure
Lead sponsor: University of Zurich; Other
Eligibility: 18 Years to 90 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Boston, Massachusetts • St Louis, Missouri

Conditions: Idiopathic Parkinson's Disease, Parkinson Disease, Depression
Interventions: Transcranial Direct Current Stimulation; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 95 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: HIV
Interventions: Imaging; Diagnostic Test
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 80 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pancreatic Cancer
Interventions: Diet Only, Diet + Exercise; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Patient Adherence, HIV Seronegativity
Interventions: brief Motivational Interviewing; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 263 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 5
States / cities: Los Angeles, California • San Diego, California • Torrance, California

Conditions: Aging, Long-Term Care
Interventions: Aim2 - Daily Mouth Care, Aim3 - Daily Mouth Care; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 1,405 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Asthma, Allergies
Interventions: Bronchoscopy, Segmental Allergen Challenge and Broncheoalveolar Lavage, PET-CT imaging(13NN perfusion/ventilation, 18FDG inflammation, and CT imaging); Biological · Procedure
Lead sponsor: Andrew D. Luster, M.D.,Ph.D.; Other
Eligibility: 18 Years to 50 Years
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension
Interventions: Physician/Pharmacist Collaborative Teams; Other
Lead sponsor: University of Iowa; Other
Eligibility: 21 Years to 85 Years
Enrollment: 179 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Preterm Labor, Preterm Birth
Interventions: PAMG-1 immunoassay; Device
Lead sponsor: Mark Santillan; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Pre-Exposure Prophylaxis (PrEP), HIV Prevention
Interventions: PrEP Decisional Aid for dissemination with Self-administered HIV test kits (DASH); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 39 Years
Enrollment: 170 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: ALS, Amyotrophic Lateral Sclerosis, Motor Neuron Disease
Interventions: No intervention; Other
Lead sponsor: ProgenaBiome; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Ventura, California

Conditions: Post-ERCP Acute Pancreatitis
Interventions: Rectal Indomethacin, Epinephrine; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 948 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Periodontal Disease, Periodontal Surgery
Interventions: Blood samples for inflammatory markers, periodontal surgery, Periodontal maintenance, Non-surgical deep cleaning; Other · Procedure
Lead sponsor: Ohio State University; Other
Eligibility: 21 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Search by objective public record fields.

Unity Cures Future (UCF) Biobank

Efficacy of Variable Lidocaine Concentrations in Tumescent Anesthesia for Pain Control During and After Endovenous Laser Procedure; Non-inferiority Trial

Management of Pediatric Chronic Rhinosinusitis in Asthmatic Children

The SNORES Randomized Clinical Trial

Continuous Monitoring and Control of Hypoglycemia

Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma

Development of a Tailored Life-Sustaining Treatment Decision Support Intervention for Stroke Surrogate Decision Makers

Remibrutinib in Real-world Clinical Practice

Assessment of Near Infrared Spectroscopy as a Diagnostic Tool in Acute Compartment Syndrome

Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis

Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI)

Exploring Mechanisms for Neuropsychiatric Symptoms of Parkinson Disease Using Transcranial Direct Current Stimulation

Application of IV 99mTc-tilmanocept for Imaging of Macrophage-specific Inflammation

Diet and Exercise After Pancreatic Cancer

Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals

Oral Hygiene in Assisted Living

T Cell Effector and Regulatory Mechanisms in Asthma

Team Management of High Blood Pressure

Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women

A Self-administered PrEP Decisional Aid for Dissemination With HIV Self-test Kits (DASH)

A Study to Explore the Role of Gut Flora in ALS

Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis

Serum Inflammatory Protein Concentration During Dental Treatment